Feroze Mahmood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Feroze Mahmood has a total of 735 co-authors. Here are the top co-authors by number of shared publications:
Robina Matyal
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
70 shared publicationsMario Montealegre-Gallegos
Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass
31 shared publications- Robina Matyal
Department of Anesthesia, Critical Care & Pain Medicine Department, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
29 shared publications - Phillip E. Hess
Department of Anesthesiology, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
27 shared publications - John D. Mitchell
Department of Anesthesiology, Pain Management, and Perioperative Care, Michigan State University College of Human Medicine and Henry Ford Health, East Lansing, Michigan
24 shared publications Peter Panzica
20 shared publications
Latest Publications
- 12 November 2026
- Published by Wolters Kluwer Health in Anesthesiology
Oxygen Delivery during Cardiopulmonary Bypass and Postoperative Mortality: A Retrospective Cohort Study
Background: Oxygen delivery during cardiopulmonary bypass reflects the balance between pump flow, hemoglobin concentration, and arterial oxygenation and is a key determinant of tissue oxygen transport. While inadequate oxygen delivery has been linked to postoperative organ dysfunction, its association with mortality remains unclear. Methods: A retrospective cohort study was conducted including 4,358 adult patients undergoing cardiac surgery with cardiopulmonary bypass at a tertiary center between 2018 and 2024. Time-weighted average indexed oxygen delivery (DO 2i ) was calculated from pump flow, arterial oxygen saturation, hemoglobin concentration, and body surface area. The primary outcome was 30-day mortality. Secondary outcomes included postoperative acute kidney injury (AKI), stroke, and intensive care unit and hospital length of stay. Associations were evaluated using multivariable regression models adjusted for demographic, clinical, and procedural factors. Results: Lower intraoperative DO 2i was associated with higher 30-day mortality. Overall, 75 patients (1.7%) died within 30 days. Each 10-ml · min −1 · m −2 decrease in DO 2i was associated with increased odds of mortality (adjusted odds ratio [OR adj ], 1.16; 95% CI, 1.09 to 1.23; P < 0.001). The adjusted 30-day mortality was 1.69% (95% CI, 1.32 to 2.05%) at the 25th percentile of DO 2i (226.2 ml · min −1 · m −2 ) compared with 0.74% (95% CI 0.41 to 1.07%) at the 75th percentile (295.6 ml · min −1 · m −2 ). Lower DO 2i was also associated with AKI (OR adj , 1.05; 95% CI, 1.03 to 1.07; P < 0.001) and with longer intensive care unit (adjusted incidence rate ratio, 1.02; 95% CI, 1.01 to 1.03; P < 0.001) and hospital length of stay (adjusted incidence rate ratio, 1.01; 95% CI, 1.01–1.02; P < 0.001) but not with stroke (OR adj , 1.00; 95% CI, 0.95 to 1.06; P = 0.877). Conclusions: Patients receiving lower intraoperative DO 2i during cardiopulmonary bypass had a higher risk of postoperative mortality, AKI, and prolonged recovery. These findings support the clinical relevance of oxygen delivery during bypass and provide a rationale for future mechanistic and interventional studies.
- 12 November 2026
- Published by Wolters Kluwer Health in Anesthesiology
Oxygen Delivery during Cardiopulmonary Bypass and Postoperative Mortality: A Retrospective Cohort Study
Background: Oxygen delivery during cardiopulmonary bypass reflects the balance between pump flow, hemoglobin concentration, and arterial oxygenation and is a key determinant of tissue oxygen transport. While inadequate oxygen delivery has been linked to postoperative organ dysfunction, its association with mortality remains unclear. Methods: A retrospective cohort study was conducted including 4,358 adult patients undergoing cardiac surgery with cardiopulmonary bypass at a tertiary center between 2018 and 2024. Time-weighted average indexed oxygen delivery (DO 2i ) was calculated from pump flow, arterial oxygen saturation, hemoglobin concentration, and body surface area. The primary outcome was 30-day mortality. Secondary outcomes included postoperative acute kidney injury (AKI), stroke, and intensive care unit and hospital length of stay. Associations were evaluated using multivariable regression models adjusted for demographic, clinical, and procedural factors. Results: Lower intraoperative DO 2i was associated with higher 30-day mortality. Overall, 75 patients (1.7%) died within 30 days. Each 10-ml · min −1 · m −2 decrease in DO 2i was associated with increased odds of mortality (adjusted odds ratio [OR adj ], 1.16; 95% CI, 1.09 to 1.23; P < 0.001). The adjusted 30-day mortality was 1.69% (95% CI, 1.32 to 2.05%) at the 25th percentile of DO 2i (226.2 ml · min −1 · m −2 ) compared with 0.74% (95% CI 0.41 to 1.07%) at the 75th percentile (295.6 ml · min −1 · m −2 ). Lower DO 2i was also associated with AKI (OR adj , 1.05; 95% CI, 1.03 to 1.07; P < 0.001) and with longer intensive care unit (adjusted incidence rate ratio, 1.02; 95% CI, 1.01 to 1.03; P < 0.001) and hospital length of stay (adjusted incidence rate ratio, 1.01; 95% CI, 1.01–1.02; P < 0.001) but not with stroke (OR adj , 1.00; 95% CI, 0.95 to 1.06; P = 0.877). Conclusions: Patients receiving lower intraoperative DO 2i during cardiopulmonary bypass had a higher risk of postoperative mortality, AKI, and prolonged recovery. These findings support the clinical relevance of oxygen delivery during bypass and provide a rationale for future mechanistic and interventional studies.
- 18 March 2026
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 33 (6) , 190-194
Emergency mitral valve transcatheter edge-to-edge repair in cardiogenic shock due to papillary muscle rupture
- 18 March 2026
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 33 (6) , 190-194
Emergency mitral valve transcatheter edge-to-edge repair in cardiogenic shock due to papillary muscle rupture
- 12 March 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (3) , e02165
Urgent Transcatheter Edge-To-Edge Mitral Valve Repair in Cardiogenic Shock: A Case Series
Urgent transcatheter edge-to-edge mitral valve repair (TEER) may offer a therapeutic alternative for patients with cardiogenic shock due to severe mitral regurgitation (MR). We reviewed 23 high-risk patients undergoing urgent TEER. Procedural success was 100%, with marked MR reduction and low periprocedural complication rates. Thirty-day and 1-year mortality were 17.4% and 30.4%, respectively. Among survivors with follow-up data, most demonstrated sustained symptomatic improvement. Percutaneous TEER may potentially serve as either definitive therapy or a temporizing intervention for patients in cardiogenic shock with prohibitive surgical risk while preserving the option for subsequent surgical mitral repair after improvement in clinical status.
- 12 March 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (3) , e02165
Urgent Transcatheter Edge-To-Edge Mitral Valve Repair in Cardiogenic Shock: A Case Series
Urgent transcatheter edge-to-edge mitral valve repair (TEER) may offer a therapeutic alternative for patients with cardiogenic shock due to severe mitral regurgitation (MR). We reviewed 23 high-risk patients undergoing urgent TEER. Procedural success was 100%, with marked MR reduction and low periprocedural complication rates. Thirty-day and 1-year mortality were 17.4% and 30.4%, respectively. Among survivors with follow-up data, most demonstrated sustained symptomatic improvement. Percutaneous TEER may potentially serve as either definitive therapy or a temporizing intervention for patients in cardiogenic shock with prohibitive surgical risk while preserving the option for subsequent surgical mitral repair after improvement in clinical status.
- 28 August 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (2) , 758-760
The Rotated Aortic Root: A Hidden Anatomical Variant Revealed by Three-dimensional Echocardiography
- 28 August 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (2) , 758-760
The Rotated Aortic Root: A Hidden Anatomical Variant Revealed by Three-dimensional Echocardiography
- 3 November 2023
- Published by Wiley in Echocardiography
- Vol. 41 (1)
Complete and incomplete bridge type double‐orifice mitral valve: Diagnosis and characterization with three‐dimensional transesophageal echocardiography
Double orifice mitral valve is a rare congenital anomaly that is often associated with other congenital cardiac abnormalities. Patients may present with valvular dysfunction or may be asymptomatic and have an incidental diagnosis of double outlet mitral valve. Whether symptoms due to this pathology are present or not it is important to accurately characterize this lesion. Three‐dimensional imaging is a powerful diagnostic modality for diagnosing and characterizing lesions such as this as highlighted in this case image series where we describe how three‐dimensional transesophageal echocardiography was utilized to characterize both complete and incomplete bridge type double orifice mitral valve.
- 3 November 2023
- Published by Wiley in Echocardiography
- Vol. 41 (1)
Complete and incomplete bridge type double‐orifice mitral valve: Diagnosis and characterization with three‐dimensional transesophageal echocardiography
Double orifice mitral valve is a rare congenital anomaly that is often associated with other congenital cardiac abnormalities. Patients may present with valvular dysfunction or may be asymptomatic and have an incidental diagnosis of double outlet mitral valve. Whether symptoms due to this pathology are present or not it is important to accurately characterize this lesion. Three‐dimensional imaging is a powerful diagnostic modality for diagnosing and characterizing lesions such as this as highlighted in this case image series where we describe how three‐dimensional transesophageal echocardiography was utilized to characterize both complete and incomplete bridge type double orifice mitral valve.
- Open Access
- 26 September 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (11)
Contents
- 26 September 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (11)
Open AccessContents
- Open Access
Double-Orifice Mitral Valve: Diagnosis and Characterization with Three-Dimensional Transesophageal Echocardiography
Double orifice mitral valve is a rare congenital anomaly that is often associated with other congenital cardiac abnormalities. Patients may present with valvular dysfunction or may be asymptomatic and have an incidental diagnosis of double outlet mitral valve. Whether symptoms due to this pathology are present or not, it is important to accurately characterize this lesion. 3-dimensional imaging is a powerful diagnostic modality for diagnosing and characterizing lesions such as this as highlighted in this case image series.
Open AccessDouble-Orifice Mitral Valve: Diagnosis and Characterization with Three-Dimensional Transesophageal Echocardiography
Double orifice mitral valve is a rare congenital anomaly that is often associated with other congenital cardiac abnormalities. Patients may present with valvular dysfunction or may be asymptomatic and have an incidental diagnosis of double outlet mitral valve. Whether symptoms due to this pathology are present or not, it is important to accurately characterize this lesion. 3-dimensional imaging is a powerful diagnostic modality for diagnosing and characterizing lesions such as this as highlighted in this case image series.
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 3257-3264
A Sequential Approach for Echocardiographic Guidance of Transseptal Puncture: The PITLOC Protocol
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 3257-3264
A Sequential Approach for Echocardiographic Guidance of Transseptal Puncture: The PITLOC Protocol
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 3244-3249
Dynamic Geometric Tricuspid Valve Assessment: Extending from Bench to Bedside
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 3244-3249
Dynamic Geometric Tricuspid Valve Assessment: Extending from Bench to Bedside